Back to Trades
Total Value
$453.1K
Filing Date
Nov 12, 2025
1 transactions
Trade Summary
On Nov 7, 2025, te Boekhorst Paul Francis Olivier, President and CEO, Director, reported $453.1K of IMMUCELL CORP /DE/ (ICCC) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $6.10. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- IMMUCELL CORP /DE/
- Ticker Symbol
- ICCC
- CIK
- 0000811641
Insider Information
- Role
- President and CEO, Director
- Location
- PORTLAND, ME
Filing Details
- Filing Date
- Nov 12, 2025
- Transaction Date
- Nov 7, 2025
- Accession Number
- 0001437749-25-034257
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 7, 2025 | ICCC derivative | 74,277 | $6.10 | Grant/Award | $453.1K |
Want live alerts when te Boekhorst Paul Francis Olivier trades again?
Download Insider Trades to track ICCC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date.